Core Viewpoint - JunTai Holdings (00630) anticipates a profit of approximately 1 million HKD for the six months ending June 30, 2025, a significant turnaround from a loss of 25.4 million HKD in the same period of 2024 [1] Financial Performance - The expected profit is attributed to an increase in revenue and gross profit by approximately 5 million HKD and 1.6 million HKD, respectively [1] - The company has shifted from a fair value loss of approximately 22.9 million HKD on trading investments for the six months ending June 30, 2024, to a fair value gain of approximately 3.4 million HKD for the six months ending June 30, 2025 [1]

Core Viewpoint - JunTai Holdings (00630) expects to report a profit of approximately HKD 1 million for the six months ending June 30, 2025, compared to a loss of HKD 25.4 million in the same period of 2024 [1] Group 1: Financial Performance - The company anticipates a turnaround from loss to profit primarily due to an increase in revenue and gross profit by approximately HKD 5 million and HKD 1.6 million, respectively [1] - The fair value loss on held-for-trading investments for the six months ending June 30, 2024, was approximately HKD 22.9 million, which has shifted to a fair value gain of approximately HKD 3.4 million for the six months ending June 30, 2025 [1]

Core Viewpoint - JunTai Holdings (00630.HK) expects to report a profit of approximately 1 million HKD attributable to shareholders for the six months ending June 30, 2025, a significant turnaround from a loss of 25.4 million HKD in the same period of 2024 [1] Group 1 - The company achieved a turnaround from loss to profit primarily due to an increase in revenue and gross profit by approximately 5 million HKD and 1.6 million HKD, respectively [1] - The company also benefited from a change in fair value of trading investments, moving from a loss of approximately 22.9 million HKD in the previous year to a gain of approximately 3.4 million HKD during the current period [1]

承董事會命 香港交易及結算所有限公司和香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並表明不會就因本公告全部或任何部分 內容而產生或因依賴該等內容而引致的任何損失承擔任何責任。 （於百慕達註冊成立之有限公司） （股份代號：630） 正面盈利預告 本公告由雋泰控股有限公司（「本公司」，連同其附屬公司統稱「本集團」）根據香 港聯合交易所有限公司證券上市規則（「上市規則」）第13.09(2)(a) 條以及證券及期 貨條例（香港法例第571章）第XIVA 部項下之內幕消息條文（定義見上市規則）而 刊發。 本公司董事會（「董事會」）謹此知會本公司股東（「股東」）及潛在投資者，根據對 本集團截至二零二五年六月三十日止六個月的未經審核簡明綜合管理賬目的初步 評估，本集團預期於截至二零二五年六月三十日止六個月錄得本公司擁有人應佔 期內溢利約1百萬港元，而於二零二四年同期錄得本公司擁有人應佔期內虧損25.4 百萬港元。本集團於截至二零二五年六月三十日止六個月實現扭虧為盈主要由於(i) 收入及毛利分別增加約5百萬港元及1.6百萬港元及(ii)由截至二零二四年六月三十 日止六個月的持作買賣投資 ...

Group 1 - The Hang Seng Index rose by 2.58% to close at 25,613.67 points on August 13 [1] - JunTai Holdings (00630.HK) closed at HKD 0.325 per share, up 14.04%, with a trading volume of 610,300 shares and a turnover of HKD 201,800, showing a volatility of 35.09% [1] - Over the past month, JunTai Holdings has had a cumulative increase of 0%, while year-to-date, it has risen by 137.5%, outperforming the Hang Seng Index by 24.48% [1] Group 2 - As of December 31, 2024, JunTai Holdings reported total revenue of HKD 34.9969 million, a year-on-year increase of 10.07%, and a net profit attributable to shareholders of -HKD 1.1418 million, a year-on-year increase of 55.21% [1] - The gross profit margin for JunTai Holdings is 36.89%, and the debt-to-asset ratio is 62.26% [1] - Currently, there are no institutional investment ratings for JunTai Holdings [2] Group 3 - The average price-to-earnings (P/E) ratio for the healthcare equipment and services industry is -0.03 times, with a median of 1.37 times [2] - JunTai Holdings has a P/E ratio of -223.64 times, ranking 56th in the industry [2] - Other companies in the industry include Jingjiu Healthcare (00648.HK) at 0.38 times, Giant Medical Holdings (02393.HK) at 0.4 times, Yihui Group (08161.HK) at 2.35 times, Global Medical (02666.HK) at 5.3 times, and Ruici Medical (01526.HK) at 5.35 times [2] Group 4 - JunTai Holdings is a company registered in Bermuda, with its shares listed on the Hong Kong Stock Exchange since 1996 [2] - The company primarily engages in the manufacturing and sales of medical equipment products, plastic mold products, and data media products [2] - The company expanded its medical equipment and plastic mold manufacturing and sales business through the acquisition of the Titron Group in October 2011 [2] Group 5 - Important date: The company will disclose its interim report for the fiscal year 2025 on August 29, 2025 [3]

Group 1 - The company, JunTai Holdings (00630.HK), announced that it will hold a board meeting on August 29, 2025, to review and approve the unaudited interim results for the six months ending June 30, 2025, and to consider the declaration of an interim dividend, if any [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何 部份內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 （於百慕達註冊成立之有限公司） （股份代號：630） 董事會召開日期 雋泰控股有限公司（「本公司」）董事會（「董事會」）謹此公佈，本公司訂於二零 二五年八月二十九日（星期五）舉行董事會會議，以（其中包括）批准本公司及其 附屬公司截至二零二五年六月三十日止六個月之未經審核綜合中期業績公告，及 考慮宣派中期股息（如有）。 承董事會命 雋泰控股有限公司 主席 賈明暉 香港，二零二五年八月十一日 於本公告日期，執行董事為賈明暉先生（主席）及張亨鑫先生；而獨立非執行董事 為葉夢美女士、歐陽銘賢先生及郭鎮輝先生。 * 僅供識別 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | | | 致：香港交易及結算所有限公司 公司名稱: AMCO United Holding Limited 呈交日期: 2025年8月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00630 | 說明 | 普通股 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 8,000,000,000 | HKD | | 0.05 HKD | | | 400,000,000 | | 增加 / 減少 (-) | | | 0 | | | HKD | | | | | 本月底結存 | | | 8,000,000,000 | HKD | | 0.05 HKD | | | 400,000,000 | 本月底法 ...

Core Viewpoint - As of July 18, 160 stocks reached their 52-week highs, with notable performances from China New Economy Investment (00080), Aoyuan Group Equity (02905), and Zhong An Holdings Group (08462) showing high growth rates of 288.89%, 55.28%, and 50.00% respectively [1][2]. Summary by Category 52-Week High Performers - China New Economy Investment (00080) closed at 0.440, with a peak price of 0.700, achieving a growth rate of 288.89% [2]. - Aoyuan Group Equity (02905) closed at 0.218, with a peak price of 0.250, achieving a growth rate of 55.28% [2]. - Zhong An Holdings Group (08462) closed at 0.221, with a peak price of 0.228, achieving a growth rate of 50.00% [2]. - Other notable performers include Hualian International (00969) with a growth rate of 40.13% and Zhongke Bio (01237) with a growth rate of 37.25% [2]. Additional High Performers - Wanma Holdings (06928) closed at 0.550 with a growth rate of 30.43% [2]. - Lepu Biopharma-B (02157) closed at 7.940 with a growth rate of 24.54% [2]. - Other stocks with significant growth include ZhiJianYueDong (06860) at 17.14% and China Jindian Group (08281) at 17.12% [2]. 52-Week Low Performers - The document also lists stocks that reached their 52-week lows, with XI Ernan CO-U (09311) showing a decline of 16.10% [6]. - Other notable declines include XI Ernan CO (07311) at -12.62% and Haotian International Construction Investment (01341) at -5.70% [6].

Company Overview - JunTai Holdings Limited is a company registered in Bermuda, primarily engaged in the manufacturing and sales of medical equipment, plastic molds, and data media products [2] Financial Performance - As of December 31, 2024, JunTai Holdings reported total revenue of 34.9969 million yuan, a year-on-year increase of 10.07% [1] - The company recorded a net profit attributable to shareholders of -1.1418 million yuan, reflecting a year-on-year growth of 55.21% [1] - The gross profit margin stood at 36.89%, while the debt-to-asset ratio was 62.26% [1] Stock Performance - On July 16, the Hang Seng Index fell by 0.29%, closing at 24,517.76 points [1] - JunTai Holdings' stock closed at 0.335 HKD per share, marking an increase of 11.67% with a trading volume of 901,900 shares and a turnover of 302,600 HKD [1] - Over the past month, JunTai Holdings has seen a cumulative increase of 316.67%, and a year-to-date increase of 150%, outperforming the Hang Seng Index by 22.58% [1] Industry Valuation - The average price-to-earnings (P/E) ratio for the healthcare equipment and services industry is -3.39 times, with a median of 1.17 times [1] - JunTai Holdings has a P/E ratio of -235.41 times, ranking 56th in the industry [1] - Comparatively, other companies in the sector have P/E ratios such as Star Medical Holdings at 0.26 times, Kingjoy Health at 0.38 times, and others ranging from 1.96 to 5.35 times [1]